We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Amazon.com Inc | NASDAQ:AMZN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.80 | -2.10% | 177.16 | 177.11 | 177.20 | 182.08 | 174.80 | 181.09 | 94,630,339 | 00:59:56 |
From May 2022 to May 2024
By Will Feuer
The U.S. Food and Drug Administration said it has issued warning letters to three companies, including Amazon.com Inc., for allegedly facilitating the sale of mole and skin tag removal products that aren't approved.
The FDA said it also sent warning letters to Ariella Naturals and Justified Laboratories. The agency posted copies of the letters online.
In one letter, dated Aug. 4 and addressed to Amazon Chief Executive Andy Jassy, an FDA official said Amazon has an opportunity to address the agency's concerns, but failure to do so "may result in legal action."
Representatives for Amazon didn't immediately return a request for comment.
"We will continue to work diligently to ensure that online retailers do not sell products that violate federal law," said Donald Ashley, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
August 09, 2022 11:22 ET (15:22 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Amazon.com Chart |
1 Month Amazon.com Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
